UK patients should understand that: Available evidence is largely from Phase 2 studies with relatively short follow-up periods Long-term cardiovascular outcome data are not yet available for either agent Phase 3 trials are ongoing, and results will inform future regulatory submissions to the MHRA UK patients interested in accessing these treatments through clinical trials may wish to consult the NIHR 'Be Part of Research' portal (bepartofresearch.nihr.ac.uk) or ClinicalTrials.gov for current recruitment opportunities
A clinician can: Review your diagnoses, medications, and lab data Explain realistic expectations for glutathione-based therapies Help choose between glutathione nasal spray , injections, or a combination Determine whether additional support like NAC nasal spray , NAD nasal spray , melatonin nasal spray , theanine nasal spray with GABA, energy support vitamin B12, or kanna nasal spray theanine fits your goals Answer common questions on dosing, frequency, stacking, and how to monitor responses Medicine is a science of uncertainty and an art of probability. William Osler, MD That reminder applies here: glutathione can be a powerful tool, but it works best as part of a thoughtful, individualized plan
Warnings: Allergic Reactions: Do not use in patients with known vitamin B12 hypersensitivity
This origin story is critical
Biological target: Mitochondrial AMPK pathway activation
PMCID: PMC9655540 Sonkar P, Sonkar A
